Atlas Analytics · FDA findings by region
Region Wise Top Issues: what FDA investigators cite in North America, EMEA, APAC and Latin America
Procedures and process validation are the two most cited issues in FDA inspections of medical device facilities in every region Atlas tracks. In North America they were tagged 1,334 and 1,312 times. For human drug facilities, CAPA, data integrity and procedures lead in North America, APAC and EMEA alike.
Atlas issue tags on FDA inspection findings · North America, Latin America, EMEA and APAC · figures read October 14, 2026
Region Wise Top Issues
4
Regions compared
1,334
Device procedure findings, North America
80
Device process validation findings, EMEA
169
Drug CAPA findings, North America
Medical devices: North America
- Procedures1,334
- Process validation1,312
- Data integrity890
- CAPA766
- Complaints765
5 more issues and the US and Canada split
Medical devices: EMEA
- Process validation80
- Procedures77
- Data integrity50
- CAPA48
- Complaints47
The country split across EMEA
Medical devices: APAC
- Procedures55
- Process validation54
- Data integrity39
- CAPA36
- Complaints34
China, India, Japan, Korea and more
Human drugs: North America
- CAPA169
- Data integrity166
- Procedures166
- Process validation166
- Investigations149
Human drugs in APAC, EMEA and Latin America
Biologics, foods, animal products and tobacco by region
In the complete dashboard
The same top-issue view for the four other FDA product categories.
Complete dashboard
Get the full dashboard for your team
This page shows a free window. Share your work email and our team will send access to the complete dashboard, including:
- Biologics, foods, animal products and tobacco by region
- The country split inside each region
- Top 10 issues per region, not just the top 5
- Human drugs in Latin America
- Filters by date range
Top FDA inspection issues for medical devices, by region
The pattern holds across geographies: written procedures, process validation and data integrity sit at the top for device facilities in North America, EMEA and APAC. Corrective and preventive action and complaint handling follow everywhere. Since February 2, 2026 those findings are written against ISO 13485 under the QMSR, covered in our ISO 13485 clause analytics and our guide to the latest FDA regulations for device manufacturers.
Latin America has far fewer device findings in the record, led by process validation and complaints with single-digit counts.
| Issue | North America | EMEA | APAC |
|---|---|---|---|
| Procedures | 1,334 | 77 | 55 |
| Process validation | 1,312 | 80 | 54 |
| Data integrity | 890 | 50 | 39 |
| CAPA | 766 | 48 | 36 |
| Complaints | 765 | 47 | 34 |
Top FDA inspection issues for human drugs, by region
For human drug facilities the top five are closer together. CAPA, data integrity, procedures and process validation are tagged within a few counts of each other in North America and APAC, which suggests investigators cite them together. A weak CAPA system shows up again in our guide to corrective and preventive action.
| Issue | North America | APAC | EMEA |
|---|---|---|---|
| CAPA | 169 | 67 | 15 |
| Data integrity | 166 | 67 | 15 |
| Procedures | 166 | 66 | 14 |
| Process validation | 166 | 67 | 14 |
Frequently asked questions
What are the most common FDA inspection findings for medical devices?
Across every region Atlas tracks, written procedures and process validation are the most cited device issues, followed by data integrity, CAPA and complaint handling. In North America they were tagged 1,334, 1,312, 890, 766 and 765 times. See what the FDA expects from device manufacturers.
Do FDA findings differ between regions?
The ranking barely changes. Procedures, process validation and data integrity lead in North America, EMEA and APAC for devices, and CAPA and data integrity lead for drugs. What changes is volume: North America carries most findings because most FDA inspections are domestic.
Which regions does the FDA inspect outside the US?
The FDA inspects facilities in Canada, Latin America, Europe, the Middle East, Africa and Asia Pacific. In 2025 the EU, China and India received the most foreign inspections, shown on the US FDA inspections analytics page.
How does Atlas assign an issue to a finding?
Atlas reads each published inspection observation and tags it with one or more topic keywords such as CAPA, data integrity or process validation. A single observation can carry several tags, so counts show how often a topic appears, not the number of inspections. The source observations are in the Form 483 database.
How do I get the full regional data?
Enter your work email in the dashboard above. The full view adds biologics, foods, animal products and tobacco, the country split inside each region and the top 10 issues. Our team reviews each request and replies by email.

